Regulations.gov document
Exhibit -22 Comparison of transdermal and subcutaneous teripara tide effect on markers of…
Supporting & Related Material · FDA-2016-P-2515 · posted Aug 23, 2016
Key facts
| Document ID | FDA-2016-P-2515-0024 |
|---|---|
| Title | Exhibit -22 Comparison of transdermal and subcutaneous teripara tide effect on markers of bone turnover and safety in postmenopausal women re Citizen Petition from Eli Lilly and Company |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2016-P-2515 |
| Posted | Aug 23, 2016 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: